A large review of randomized clinical trials has found that calcium supplements, vitamin D supplements and the two taken together offered little to no clinically meaningful benefit in preventing fractures or falls among the adults represented in the evidence. The finding challenges the routine use of the widely taken supplements as a broad preventive strategy, particularly for older adults.
The systematic review and meta-analysis reported by BMJ Group combined 69 randomized trials involving 153,902 adults. Its conclusions do not mean that calcium in food is unimportant, that vitamin D deficiency should be ignored, or that people being treated for osteoporosis should stop supplements or prescribed medicines. Rather, the review addresses whether assigning these supplements, compared with placebo or no treatment, prevents fractures and falls in the populations studied.
Separate supplement strategies showed the same broad pattern
The review evaluated calcium alone, vitamin D alone and combined calcium-vitamin D supplementation rather than treating them as a single intervention. For any fracture, calcium alone had little to no clinically meaningful effect in 11 trials with 9,067 participants, an estimate the researchers rated as moderate-certainty evidence.
For vitamin D alone, the finding was supported by 36 trials involving 92,045 participants and was rated high-certainty evidence. Combined calcium and vitamin D produced a similar result in 15 trials involving 51,126 participants, also with high-certainty evidence. The review also found an overall pattern of little to no meaningful effect for particular fracture types, including hip fractures, and for falls, with much of that evidence rated moderate to high certainty.
The distinction between a statistically detectable change and one likely to matter to patients is important here. The investigators used prespecified thresholds for clinical meaningfulness, so their conclusion was not simply that every estimate was exactly zero. It was that the observed evidence did not show benefits large enough to support routine supplementation for the prevention outcomes examined.
Because the analysis synthesized randomized controlled trials, it is better suited than observational research to assess whether being assigned a supplement causes a difference in fractures or falls. But even randomized evidence has boundaries: its relevance depends on who was enrolled, the doses and treatment patterns tested, and the outcomes captured. The 153,902-person total describes the full review; the smaller figures for each treatment approach refer to the specific any-fracture analyses.
What the findings do — and do not — apply to
The authors said their results remained consistent in analyses accounting for characteristics including age, sex, prior fractures, previous falls and average dietary calcium intake. That consistency weakens the case that routine supplementation prevents these events for the broad groups represented across the trials.
Still, the review has limits that matter in clinical practice. Trial quality varied, and some analyses drew on relatively few trials or participants. The authors cautioned that the findings might not apply to people with specific bone disorders or to people receiving drug treatment for osteoporosis. Those are not minor exceptions: people at higher risk may have different medical needs than generally healthy adults taking supplements for prevention.
Nor does the research test the proposition that dietary calcium has no role in skeletal health. Supplements are a delivery method, not a substitute for the nutrients’ biological functions. The Bone Health & Osteoporosis Foundation advises people to obtain recommended calcium from food when possible and to use supplements as needed to reach the recommended amount. It also says people with osteoporosis or low bone mass should discuss vitamin D status with a health care provider.
That guidance reflects a practical difference between treating a documented shortfall or managing a diagnosed condition and recommending a pill to everyone in hopes of avoiding a future fracture or fall. The new analysis directly calls the latter strategy into question; it does not establish that supplements are ineffective in every clinical circumstance.
Falls and fractures have different prevention pathways
Fractures and falls are related but not interchangeable outcomes. Bone strength can influence whether a fall results in a fracture, while falls also depend on balance, muscle strength, vision, medications, mobility, home hazards and other factors. A nutritional supplement would therefore not necessarily be expected to have a large effect on falls themselves.
A linked editorial discussed in the BMJ Group report pointed instead to evidence for balance and resistance exercise, as well as approaches that combine exercise with hazard assessment or individualized education, to prevent falls and fall-related injuries. Those interventions were not the subject of this supplement meta-analysis, so the review cannot compare their effectiveness directly with calcium or vitamin D.
For patients, the immediate implication is not to make abrupt changes to a treatment plan. Someone taking calcium or vitamin D because of a diagnosed deficiency, malabsorption problem, low dietary intake, osteoporosis regimen or another individualized reason may need a different approach than someone taking the products for general prevention. Decisions also need to account for total intake from diet and supplements, other medicines and a person’s fracture risk.
The review’s authors said routine calcium, vitamin D or combined supplementation is not supported for preventing fractures and falls on the current evidence, and called for recommendations to be reconsidered. They and the linked editorial also identified a remaining evidence gap: adequately powered trials in higher-risk groups are needed before broad findings in mostly general populations are applied to every person vulnerable to bone loss or fractures.